Fox backs Civitas's Phase I trial of inhaled L-dopa Parkinson's candidate
30 November 2011
Nancy Faigen
Please Login to read the full article.
30 November 2011
Nancy Faigen
nancy.faigen@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Addex seeks partner for dyskinesia drug after positive Phase II
- Nycomed to co-market Orion's Easyhaler products in Europe and MENA region
- Australia's Biota merges with Nabi for cash and exposure to larger US investment market
- Cipla eyes overhaul as it ponders own ANDAs, expanding overseas presence and venture financing
ANALYSIS
Other Informa Analysis
FEATURES
Other Informa Features
EVENTS
Today
Le Plaza Hotel, Brussels, Belgium
Today
Diplomat Hotel, Prague, Czech Republic
Today
Business Design Centre, London
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
